Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mujdat Zeybel"'
Autor:
Jennifer Kathleen Quint, Christopher Denton, Fasihul Khan, Iain Stewart, Gisli Jenkins, Ali-Reza Mohammadi-Nejad, Dorothee Auer, Karen Piper Hanley, Michael Nation, Harley H Y Kwok, Jane Paxton, Elizabeth Robertson, Anna Duckworth, Chris Scotton, Aloysious Aravinthan, Hilary Longhurst, Mujdat Zeybel, Louise V Wain, Philip W Stone, Richard J Allen, Maria Kaisar, Lisa Chakrabarti, Georgie May Massen, Andrew Thorley, Anthony Harbottle, Armando Mendez Villalon, Daniel Lea, Ebrima Joof, Eleanor Cox, Elizabeth Eves, Emma Blamont, Gina Parcesepe, Gordon W. Moran, Guruprasad P. Aithal, Kate Frost, Leo Casmino, Margot Roeth, Martin Craig, Mohammad Alireza Kisomi
Publikováno v:
Open Heart, Vol 11, Iss 1 (2024)
Background and aims Hypertension is a leading risk factor for cardiovascular disease. Electronic health records (EHRs) are routinely collected throughout a person’s care, recording all aspects of health status, including current and past conditions
Externí odkaz:
https://doaj.org/article/2f2add5b3f1648c1a56b0060a91009fa
Autor:
Mujdat Zeybel, Ozlem Altay, Muhammad Arif, Xiangyu Li, Hong Yang, Claudia Fredolini, Murat Akyildiz, Burcin Saglam, Mehmet Gokhan Gonenli, Dilek Ural, Woonghee Kim, Jochen M Schwenk, Cheng Zhang, Saeed Shoaie, Jens Nielsen, Mathias Uhlén, Jan Borén, Adil Mardinoglu
Publikováno v:
Molecular Systems Biology, Vol 17, Iss 10, Pp 1-18 (2021)
Abstract Nonalcoholic fatty liver disease (NAFLD) refers to excess fat accumulation in the liver. In animal experiments and human kinetic study, we found that administration of combined metabolic activators (CMAs) promotes the oxidation of fat, atten
Externí odkaz:
https://doaj.org/article/458a964c837f412a952dd9635ecd9b5f
Autor:
Mujdat Zeybel, Muhammad Arif, Xiangyu Li, Ozlem Altay, Hong Yang, Mengnan Shi, Murat Akyildiz, Burcin Saglam, Mehmet Gokhan Gonenli, Buket Yigit, Burge Ulukan, Dilek Ural, Saeed Shoaie, Hasan Turkez, Jens Nielsen, Cheng Zhang, Mathias Uhlén, Jan Borén, Adil Mardinoglu
Publikováno v:
Advanced Science, Vol 9, Iss 11, Pp n/a-n/a (2022)
Abstract Metabolic dysfunction‐associated fatty liver disease (MAFLD) is a complex disease involving alterations in multiple biological processes regulated by the interactions between obesity, genetic background, and environmental factors including
Externí odkaz:
https://doaj.org/article/f0323763de524d1baed15e3811c0095e
Autor:
Ali Taş, Ali B Kızılırmak, Hale Yapici-Eser, Mujdat Zeybel, Emine Sekerdag, Yağmur Çetin-Taş, Sercin Karahuseyinoglu, Esra Özkan, Erdost Yildiz, Yasemin Gursoy-Ozdemir
Publikováno v:
Metabolic Brain Disease. 36:2553-2566
Hypertension (HT) is one of the main causes of vascular dementia, lead to cognitive decline. Here, we investigated the relationship between cerebral microvessels, pericytes, extracellular matrix (ECM) accumulation, blood–brain barrier (BBB) breakdo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::743a90b75c616de7687b4fb2a2f9f9f1
https://doi.org/10.1007/s11011-021-00767-8
https://doi.org/10.1007/s11011-021-00767-8
Autor:
Buket Yigit, Ekin Ozgonul, Omer Yaman, Burge Ulukan, Yagmur Cetin Tas, Berna Morova, Musa Aydin, Yigit Uysalli, Elif Demirtas, Mert Erkan, Yasemin Gursoy Ozdemir, Sercin Karahuseyinoglu, Cihan Yurdaydin, Murat Akyildiz, Abhishek Sheth, Hale Kirimlioglu, Murat Dayangac, Onur Ferhanoglu, Alper Kiraz, Mujdat Zeybel
Background and aims: Liver fibrosis is a dynamic process of fibrogenesis and fibrolysis traditionally evaluated by liver biopsy. Accurate assessment of hepatic fibrosis is vital for optimal biomarker and drug development in the era of NASH clinical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7baec850081ea2a2c850ecdd791ae85
https://hdl.handle.net/20.500.12511/9645
https://hdl.handle.net/20.500.12511/9645
Autor:
Mujdat Zeybel, Derek A Mann
Publikováno v:
Encyclopedia of Cell Biology ISBN: 9780128216248
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07076ea19bf2e451a82e9d070b298eeb
https://doi.org/10.1016/b978-0-12-821618-7.00262-5
https://doi.org/10.1016/b978-0-12-821618-7.00262-5
Autor:
Sena Arici, Adriana Palom, Mesut Gumussoy, Ramazan Idilman, Genco Gencdal, Rafael Esteban, Mujdat Zeybel, Maria Buti, Cihan Yurdaydin
Publikováno v:
Journal of Hepatology. 77:S297-S298
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f27e3daa42881b3f45df1dd3d564540
https://doi.org/10.1016/s0168-8278(22)00961-8
https://doi.org/10.1016/s0168-8278(22)00961-8
Autor:
Woong-Hee Kim, Muhammad Arif, Ozlem Altay, Xiangyu Li, Hong Yang, Mujdat Zeybel, Claudia Fredolini, Mathias Uhlén, Jochen M. Schwenk, Jan Borén, Saeed Shoaie, Adil Mardinoglu, Jens Nielsen, Murat Akyildiz, Mehmet Gokhan Gonenli, Cheng Zhang, Dilek Ural, Burcin Saglam
Publikováno v:
Molecular Systems Biology
Molecular Systems Biology, Vol 17, Iss 10, Pp n/a-n/a (2021)
Molecular Systems Biology, Vol 17, Iss 10, Pp n/a-n/a (2021)
Nonalcoholic fatty liver disease (NAFLD) refers to excess fat accumulation in the liver. In animal experiments and human kinetic study, we found that administration of combined metabolic activators (CMAs) promotes the oxidation of fat, attenuates the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ea8bfb563d56984ec81e3de36ec0ef
https://pubmed.ncbi.nlm.nih.gov/34694070
https://pubmed.ncbi.nlm.nih.gov/34694070
Autor:
Ebru Yilmaz, Alisan Kayabolen, Semra Cemre Atalar, Buket Yigit, Burge Ulukan, Mujdat Zeybel, Tugba Bagci-Onder
Publikováno v:
Cancer Research. 82:6255-6255
Induction of apoptosis in cancer cells via de-repressing dormant pro-apoptotic genes might be a successful therapeutic strategy. In this study, we utilized several dCas9-mediated CRISPR activation (CRISPRa) systems to activate two key pro-apoptotic g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f9049785f948e313a08c63573931afd
https://doi.org/10.1158/1538-7445.am2022-6255
https://doi.org/10.1158/1538-7445.am2022-6255
Autor:
Cheng Zhang, Jens Nielsen, Adil Mardinoglu, Muhammad Arif, Ozlem Altay, Xiangyu Li, Burcin Saglam, Dilek Ural, Woong-Hee Kim, Mujdat Zeybel, Saeed Shoaie, Mathias Uhlén, Hong Yang, Murat Akyildiz, Jochen M. Schwenk, Mehmet Gokhan Gonenli, Claudia Fredolini, Jan Borén
Nonalcoholic fatty liver disease (NAFLD) refers to excess fat accumulation in the liver. In animal experiments and human kinetic study, we found that administration of combined metabolic activators (CMA) promotes the oxidation of fat, attenuates the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7997512d2d6c49a9e82aa3b73f0394ae
https://doi.org/10.1101/2021.05.20.21257480
https://doi.org/10.1101/2021.05.20.21257480